Abstract

The clathrin heavy chain N-terminal domain interacts with endocytic adapter proteins via clathrin binding motifs to assemble clathrin triskelia into cages. However, the precise mechanism of clathrin assembly is not yet known. Clathrin assembly protein AP180 has more clathrin binding motifs than any other endocytic protein and has a major role in the assembly of the clathrin coat during synaptic vesicle biogenesis. We now demonstrate that some of the previously identified binding motifs in AP180 may be non-functional and that a non-conventional clathrin binding sequence has a major influence on AP180 function. The related protein, clathrin assembly lymphoid myeloid leukemia protein (CALM), has fewer clathrin binding motifs and functions ubiquitously in clathrin-mediated endocytosis. The C-terminal ~16 kDa sub-domain in AP180, which has relatively high similarity with CALM, was shown in earlier work to have an unexplained role in clathrin binding. We identified the specific sequences in this sub-domain that bind to clathrin. Evidence for a role for these sequences in promoting clathrin binding was examined using in vitro and ex vivo experiments that compared the clathrin binding ability of site mutants with the wild type sequence. A sequence conserved in both AP180 and CALM (LDSSLA[S/N]LVGNLGI) was found to be the major interaction site and mutation caused a deficit in clathrin assembly, which is the first example of a mutation having this effect. In contrast, single or double mutation of DL(L/F) motifs in full length AP180 had no significant effect on clathrin binding, despite higher clathrin affinity for isolated peptides containing these motifs. We conclude that the novel clathrin interaction sites identified here in CALM and AP180 have a major role in how these proteins interface with clathrin. This work advances the case that AP180 and CALM are required to use a combination of standard clathrin N-terminal domain binding motifs and the sequence identified here for optimal binding and assembling clathrin.

Highlights

  • An early event in clathrin-mediated endocytosis (CME) is the formation of a clathrin-coated pit at the plasma membrane which requires clathrin binding to endocytic adaptor proteins [1,2]

  • Each experiment had the same series of assembly protein 180 kDa (AP180) clathrin and adaptor protein binding (CLAP) domain peptides, which served as positive controls and enabled the spot intensity for the two experiments to be compared (Fig 1B)

  • Since CME relies on either AP180 or clathrin assembly lymphoid myeloid leukemia protein (CALM) for the formation of a clathrin coat, these two proteins are essential for regulated vesicle biogenesis

Read more

Summary

Introduction

An early event in clathrin-mediated endocytosis (CME) is the formation of a clathrin-coated pit at the plasma membrane which requires clathrin binding to endocytic adaptor proteins [1,2]. There are a multitude of adaptor, accessory and uncoating proteins that interact with the clathrin heavy chain N-terminal domain (NTD) throughout various stages of CME. All of these interactions are thought to involve clathrin binding motifs (CBMs), which target multiple NTD binding sites [4,5,6,7,8]. The NTD has three protein binding sites which can accommodate CBMs [5,8] and AP180 binds clathrin heavy chain in a ratio of 1:3 [3,10]. The multiple CBMs in AP180 appear to provide the structural basis for assembly of a clathrin cage during SVE [7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call